Minimal residual disease (MRD) detection acts a critical role in the management of lymphoma. Traditionally, MRD assessment depends on invasive bone marrow biopsies, which can be carry risks and discomfort for patients. https://esmeekqxo777244.blog5.net/84402766/liquid-biopsy-for-minimal-residual-disease-detection-in-lymphoma